Hipolin shareholders approve re-designation of director as MD at 33rd AGM
- Hipolin Limited held its 33rd AGM on September 29, 2026, via video conferencing
- Shareholders approved the re-designation of Shaileshkumar Jayantilal Shah as Executive Managing Director
- Audited financial statements for FY26 were adopted through an ordinary resolution
- Only one shareholder question was received and answered during the meeting
*this image is generated using AI for illustrative purposes only.
Hipolin Limited held its 33rd Annual General Meeting on September 29, 2026, via video conferencing. The meeting focused on adopting financial statements and approving key leadership changes.
Shareholders passed an ordinary resolution to adopt the audited financial statements for FY26, along with the Board and Auditors' reports. They also approved the re-appointment of Shaileshkumar Jayantilal Shah as a Director, who retired by rotation and offered himself for re-election.
A special resolution was passed to re-designate Mr. Shah from Non-Executive to Executive Managing Director. This change includes the approval of his remuneration package, marking a shift in the company's executive structure.
The meeting commenced at 4:08 pm and concluded at 4:35 pm. Remote e-voting facilities were available from September 25 to September 28, 2026. Only one shareholder question was received and addressed by Director Daxesh Shah during the session.
Resolutions passed
| Resolution | Type | Details |
|---|---|---|
| Adoption of Financials | Ordinary | Adopted audited financial statements for FY26 |
| Director Re-appointment | Ordinary | Re-appointed Shaileshkumar Jayantilal Shah |
| MD Re-designation | Special | Re-designated Shah as Executive Managing Director |
Detailed voting results will be declared within 48 hours and submitted to NSDL and BSE. The scrutinizer for the meeting was Megha Samdani of M/s M K Samdani & Co.
Historical Stock Returns for Hipolin
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.77% | +8.82% | -8.42% | 0.0% | +9.49% | 0.0% |
How will Mr. Shah's transition to Executive Managing Director impact Hipolin Limited's strategic decision-making speed and operational efficiency?
What specific growth initiatives or market expansions are expected under the new executive leadership structure?
How might the re-designation of the MD influence investor sentiment and the company's valuation in the near term?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
